KOBO BIOTECH LIMITED (KOBO.BO)
INR 3.0
(-5.0%)
INR 3.0
(-5.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 2.48 Million INR | -73.78% |
| 2022 | 9.45 Million INR | 105.5% |
| 2021 | -172.01 Million INR | -879.75% |
| 2020 | 22.06 Million INR | -15.4% |
| 2019 | 26.07 Million INR | -12.91% |
| 2018 | 29.94 Million INR | -2.87% |
| 2017 | 30.82 Million INR | -21.68% |
| 2016 | 39.36 Million INR | 97.57% |
| 2015 | 19.92 Million INR | -85.81% |
| 2014 | 140.39 Million INR | -24.21% |
| 2013 | 185.23 Million INR | -34.66% |
| 2012 | 283.49 Million INR | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 654 Thousand INR | -73.31% |
| 2023 Q1 | 2.28 Million INR | -71.12% |
| 2023 Q4 | 2.45 Million INR | 20.45% |
| 2023 Q3 | 2.03 Million INR | 3.83% |
| 2023 Q2 | 1.95 Million INR | -14.15% |
| 2023 FY | 8.72 Million INR | -7.75% |
| 2022 Q1 | 3.3 Million INR | -96.42% |
| 2022 FY | 9.45 Million INR | 105.5% |
| 2022 Q4 | 7.9 Million INR | 376.89% |
| 2022 Q3 | 1.65 Million INR | -20.98% |
| 2022 Q2 | 2.09 Million INR | -36.63% |
| 2021 Q4 | 92.35 Million INR | 2929.92% |
| 2021 FY | -172.01 Million INR | -879.75% |
| 2021 Q3 | 3.04 Million INR | -56.4% |
| 2021 Q2 | 6.99 Million INR | 166.12% |
| 2021 Q1 | 2.62 Million INR | 21.95% |
| 2020 Q2 | 20.88 Million INR | 5.94% |
| 2020 Q4 | 2.15 Million INR | -89.95% |
| 2020 FY | 22.06 Million INR | -15.4% |
| 2020 Q1 | 19.71 Million INR | 592.15% |
| 2020 Q3 | 21.42 Million INR | 2.61% |
| 2019 Q4 | 2.84 Million INR | -86.38% |
| 2019 Q2 | 21.47 Million INR | 1.43% |
| 2019 FY | 26.07 Million INR | -12.91% |
| 2019 Q1 | 21.17 Million INR | 92.72% |
| 2019 Q3 | 20.9 Million INR | -2.68% |
| 2018 Q3 | 22.4 Million INR | 1.16% |
| 2018 Q2 | 22.15 Million INR | -51.19% |
| 2018 Q1 | 45.38 Million INR | 87.85% |
| 2018 FY | 29.94 Million INR | -2.87% |
| 2018 Q4 | 10.98 Million INR | -50.97% |
| 2017 Q2 | 25.32 Million INR | 6.8% |
| 2017 Q3 | 22.46 Million INR | -11.29% |
| 2017 Q1 | 23.71 Million INR | -30.75% |
| 2017 FY | 30.82 Million INR | -21.68% |
| 2017 Q4 | 24.15 Million INR | 7.53% |
| 2016 Q1 | 27.82 Million INR | -43.41% |
| 2016 FY | 39.36 Million INR | 97.57% |
| 2016 Q4 | 34.24 Million INR | 29.01% |
| 2016 Q3 | 26.54 Million INR | -7.19% |
| 2016 Q2 | 28.59 Million INR | 2.78% |
| 2015 Q1 | 26.06 Million INR | -10.26% |
| 2015 Q2 | 41.21 Million INR | 58.12% |
| 2015 FY | 19.92 Million INR | -85.81% |
| 2015 Q4 | 49.17 Million INR | 41.03% |
| 2015 Q3 | 34.86 Million INR | -15.41% |
| 2014 Q1 | 42.13 Million INR | 0.0% |
| 2014 FY | 140.39 Million INR | -24.21% |
| 2014 Q3 | 38.65 Million INR | -9.59% |
| 2014 Q4 | 29.04 Million INR | -24.86% |
| 2014 Q2 | 42.75 Million INR | 1.46% |
| 2013 FY | 185.23 Million INR | -34.66% |
| 2012 FY | 283.49 Million INR | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Beryl Drugs Limited | 93.77 Million INR | 97.355% |
| ANG Lifesciences India Limited | 219.92 Million INR | 98.872% |
| Add-Shop E-Retail Limited | 146.52 Million INR | 98.307% |
| Bacil Pharma Limited | 1.87 Million INR | -32.31% |
| BDH Industries Limited | 57.03 Million INR | 95.652% |
| Cian Healthcare Limited | 59.19 Million INR | 95.811% |
| Chemo Pharma Laboratories Limited | 1.94 Million INR | -27.375% |
| Colinz Laboratories Limited | 31.19 Million INR | 92.051% |
| Mercury Laboratories Limited | 217.24 Million INR | 98.858% |
| Concord Drugs Limited | 91.83 Million INR | 97.299% |
| Deccan Health Care Limited | 36.24 Million INR | 93.157% |
| DECIPHER LABS LIMITED | 277.6 Million INR | 99.107% |
| Phaarmasia Limited | 50.52 Million INR | 95.092% |
| Gujarat Terce Laboratories Limited | 132.41 Million INR | 98.127% |
| Gujarat Themis Biosyn Limited | 156.84 Million INR | 98.419% |
| Hindustan Bio Sciences Limited | 2.6 Million INR | 4.924% |
| Jenburkt Pharmaceuticals Limited | 437.2 Million INR | 99.433% |
| KIMIA BIOSCIENCES LIMITED | 149.52 Million INR | 98.341% |
| Kwality Pharmaceuticals Limited | 248.93 Million INR | 99.004% |
| Makers Laboratories Limited | 83.1 Million INR | 97.016% |
| Medi-Caps Limited | 93.11 Million INR | 97.337% |
| MedPlus Health Services Limited | 2.42 Billion INR | 99.898% |
| Parmax Pharma Limited | 99.31 Million INR | 97.503% |
| Parnax Lab Limited | 80.59 Million INR | 96.923% |
| Patidar Buildcon Limited | 1.81 Million INR | -36.941% |
| PRAVEG LIMITED | 77.18 Million INR | 96.787% |
| Sastasundar Ventures Limited | 846.78 Million INR | 99.707% |
| Smruthi Organics Limited | 261.73 Million INR | 99.052% |
| SUDARSHAN PHARMA INDUSTRIES LI | 146.09 Million INR | 98.302% |
| Sunil Healthcare Limited | 438.1 Million INR | 99.434% |
| Syschem (India) Limited | 64.13 Million INR | 96.133% |
| Sanjivani Paranteral Limited. | 208.87 Million INR | 98.813% |
| Transchem Limited | 8.47 Million INR | 70.731% |
| SHAMROCK INDUSTRIAL CO.LTD. | 1.52 Million INR | -62.73% |
| Trinity League India Limited | -1.08 Million INR | 328.361% |
| Tyche Industries Limited | 182.04 Million INR | 98.638% |
| Source Natural Foods and Herbal Supplements Limited | 31.85 Million INR | 92.215% |
| Trident Lifeline Limited | 46.87 Million INR | 94.709% |
| Denis Chem Lab Limited | 453.36 Million INR | 99.453% |
| Vista Pharmaceuticals Limited | 20.16 Million INR | 87.702% |
| Panchsheel Organics Limited | 68.15 Million INR | 96.361% |
| Zenith Healthcare Limited | 45.97 Million INR | 94.606% |
| Zenlabs Ethica Limited | 57.89 Million INR | 95.716% |
| Vivanza Biosciences Limited | 4.55 Million INR | 45.554% |
| Ishita Drugs and Industries Limited | 16.46 Million INR | 84.94% |
| Vikram Thermo (India) Limited | 104.27 Million INR | 97.622% |
| SHELTER PHARMA LIMITED | 12.3 Million INR | 79.838% |
| Vasundhara Rasayans Limited | 145.5 Million INR | 98.296% |
| Bharat Immunologicals & Biologicals Corporation Limited | 184.08 Million INR | 98.653% |
| Roopa Industries Limited | 24.63 Million INR | 89.933% |
| PANJON LTD. | 33.77 Million INR | 92.658% |
| Pharmaids Pharmaceuticals Limited | 76.49 Million INR | 96.758% |
| TIAAN CONSUMER LIMITED | 107 Thousand INR | -2217.757% |
| Anuh Pharma Limited | 263.04 Million INR | 99.057% |
| Crestchem Limited | 50.8 Million INR | 95.118% |
| Emmessar Biotech & Nutrition Limited | 4.32 Million INR | 42.619% |
| Sandu Pharmaceuticals Limited | 212.9 Million INR | 98.835% |
| Fredun Pharmaceuticals Limited | 360.45 Million INR | 99.312% |
| Trimurthi Limited | 4.81 Million INR | 48.451% |
| Shukra Pharmaceuticals Limited | 83.05 Million INR | 97.014% |
| Norris Medicines Limited | 18.2 Million INR | 86.377% |
| Veerhealth Care Limited | 15.38 Million INR | 83.877% |
| Lactose (India) Limited | 111.66 Million INR | 97.779% |
| OXYGENTA PHARMACEUTICAL LIMITE | 23.78 Million INR | 89.571% |
| Ambalal Sarabhai Enterprises Limited | 280.83 Million INR | 99.117% |
| Gennex Laboratories Limited | 130.37 Million INR | 98.098% |
| Godavari Drugs Limited | 359.01 Million INR | 99.309% |
| Zenotech Laboratories Limited | 94.82 Million INR | 97.385% |
| Shree Ganesh Remedies Limited | 104.13 Million INR | 97.618% |
| Bharat Parenterals Limited | 255.97 Million INR | 99.031% |
| Coral Laboratories Limited | 189.75 Million INR | 98.693% |
| Evoq Remedies Limited | 4.51 Million INR | 45.096% |
| Kerala Ayurveda Limited | 399.64 Million INR | 99.379% |
| Natural Capsules Limited | 444.7 Million INR | 99.442% |
| Auro Laboratories Limited | 157.37 Million INR | 98.424% |